Chinese Journal of Pharmaceuticals
|
2022, 53(2): 272-276
• Pharmaceutical Management & Information •
A Brief Comment on the FDA's Regulatory Concept and Promotion Measures of Emerging Technologies
Full
Yuan CHEN
1, Jiangping DONG
2
Affiliations
- 1.School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016
- 2.Center for Food and Drug Inspection of NMPA, Beijing 100044
Published: 2022-02-10
doi: 10.16522/j.cnki.cjph.2022.02.015
Outline
陈园, 董江萍.
美国FDA对新兴技术监管理念与促进措施简评.
中国医药工业杂志,
2022
, 53
(2)
: 272
-276
.
DOI: 10.16522/j.cnki.cjph.2022.02.015
Yuan CHEN, Jiangping DONG.
A Brief Comment on the FDA's Regulatory Concept and Promotion Measures of Emerging Technologies[J].
Chinese Journal of Pharmaceuticals,
2022
, 53
(2)
: 272
-276
.
DOI: 10.16522/j.cnki.cjph.2022.02.015
Year 2022 volume 53 Issue 2
90
19
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2022.02.015
- Receive Date:2021-10-21
- Online Date:2026-11-12
- Published:2022-02-10